HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

URAT1 gene polymorphisms influence uricosuric action of losartan in hypertensive patients with hyperuricemia.

AbstractAIMS:
To explore the effect of urate transporter 1 (URAT1) polymorphisms on the hypertensive patients with hyperuricemia and the uricosuric action of losartan therapy among hypertensive patients with hyperuricemia.
METHODS:
101 hypertensive patients with hyperuricemia were detected the genotypes of URAT1 rs1529909 and rs3825016 and undergo a 2-weeks following losartan treatment. Before and after treatment, serum uric acid (SUA) and other clinical data were compared between different genotypes of URAT1 patients.
RESULTS:
The frequency of rs3825016 (C/T) CT genotype was significant higher in the hypertensive patients with hyperuricemia than that in the healthy controls (32.7 vs 18.8%; p = 0.02). After lorsatan treatment, the patients with the rs3825016 (C/T) or rs1529909 (T/C) mutant genotypes had lower decreased value (DV) of SUA compared with the patients who are wild-type of the variant (p = 0.001 and p < 0.001, respectively). Combined the two variants together, the DV of SUA in two variants both wild-type patients higher than that in the two variants mutant patients (p < 0.0001).
CONCLUSION:
These results suggest that URAT1 rs3825016 and rs1529909 polymorphisms influence the uricosuric action of losartan. Original submitted 20 August 2014; Revision submitted 15 April 2015.
AuthorsHong Sun, Qiang Qu, Jian Qu, Xiao-Ya Lou, Yan Peng, Ying Zeng, Guo Wang
JournalPharmacogenomics (Pharmacogenomics) Vol. 16 Issue 8 Pg. 855-63 (Jul 2015) ISSN: 1744-8042 [Electronic] England
PMID26086348 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Organic Anion Transporters
  • Organic Cation Transport Proteins
  • SLC22A12 protein, human
  • Uricosuric Agents
  • Losartan
Topics
  • Aged
  • Female
  • Genetic Association Studies
  • Genotype
  • Humans
  • Hypertension (complications, drug therapy, genetics)
  • Hyperuricemia (complications, drug therapy, genetics)
  • Losartan (administration & dosage, adverse effects)
  • Male
  • Middle Aged
  • Organic Anion Transporters (genetics)
  • Organic Cation Transport Proteins (genetics)
  • Polymorphism, Single Nucleotide
  • Uricosuric Agents (administration & dosage, adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: